Health ❯Healthcare

Chronic Conditions

Chronic Conditions Pharmaceuticals Medical Research Research Clinical Trials Public Health Medications Clinical Research Patient Care Medical Treatments

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Experts link dry mouth, acid reflux, and vomiting caused by GLP-1 drugs like Ozempic to tooth decay and gum disease, urging preventive dental care.

Cardiologist Follow-Up Found to Halve Mortality Risk in Heart Failure Patients

WHO to Endorse GLP-1 Weight-Loss Drugs, Calls for Global Access

Innovative Injectable Polymer Shows Promise in Post-Heart Attack Tissue Repair

Study Finds Toddlers with Chronic Conditions Face Twice the RSV Hospitalization Risk

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Mid-Afternoon Inhaler Use Found to Improve Asthma Control in New Study

GLP-1 Drugs Like Ozempic Linked to Lower Dementia Risk in New Studies

UK A&E Departments Failing to Deliver Time-Critical Medications on Time, Report Finds

FDA Approves VYKAT XR, First Therapy for Hyperphagia in Prader-Willi Syndrome

Study Finds 90% of Non-Surgical Back Pain Treatments Lack Effectiveness

Nice Proposes Annual Weight Monitoring for Millions with Long-Term Health Conditions

NHS Approves First Daily Pill for Endometriosis Treatment

UK Drug Shortages Threaten Patient Safety, Pharmacists Warn

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Study Finds Paxlovid Offers Limited Benefits for Vaccinated Seniors

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients

Stem Cell Heart Patches Show Promise in Early Trials

Study Maps Broad Health Impacts of Popular GLP-1 Weight-Loss Drugs